We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avacta Group PLC 21 January 2025 Avacta Group plc ("Avacta" or the "Group" or the "Company") Issue of Equity and Total Voting Rights LONDON and PHILADELPHIA - Jan 21 2025 - Avacta...
Avacta Group PLC 16 January 2025 Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland...
The following is a round-up of London-listed company director and manager changes announced on Monday and last week a ...
Avacta Group PLC 13 January 2025 Avacta Appoints Brian Hahn as Chief Financial Officer - Brian brings 25 years' senior financial and operational experience, including leading...
Avacta Group PLC 12 December 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Dose Escalation and Recommended Dose for Expansion (RDE) Arms of the AVA6000 Phase 1a...
Avacta Group PLC 30 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") R&D Spotlight focusing on pre|CISION® technology and pipeline advances LONDON - Oct...
Avacta Group PLC 28 October 2024 28 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Block Listing Six Monthly Return Avacta Group plc (AIM:...
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona LONDON – Oct...
Avacta Group PLC 24 October 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular...
Avacta Group PLC 21 October 2024 Avacta Group plc ("Avacta" or the "Group" or the "Company") Issue of Equity and Total Voting Rights London - Oct. 21, 2024 - Avacta Therapeutics (AIM:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.5 | -3.0612244898 | 49 | 49.5 | 47.5 | 1161326 | 48.51585455 | DE |
4 | -4.5 | -8.65384615385 | 52 | 60.5 | 46.5 | 1259785 | 51.01028626 | DE |
12 | -1.5 | -3.0612244898 | 49 | 60.5 | 42.5 | 1397185 | 48.46989161 | DE |
26 | -13.5 | -22.131147541 | 61 | 77.5 | 42 | 1740324 | 55.88491927 | DE |
52 | -61 | -56.2211981567 | 108.5 | 108.5 | 39.75 | 2329934 | 56.57715352 | DE |
156 | -40 | -45.7142857143 | 87.5 | 187.5 | 38.5 | 1876469 | 90.68331653 | DE |
260 | 24.25 | 104.301075269 | 23.25 | 290 | 13.5 | 2650499 | 115.57305846 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions